Enochian Biosciences Inc. (ENOB)
NASDAQ: ENOB
· Real-Time Price · USD
0.71
0.01 (1.43%)
At close: Aug 04, 2023, 9:58 PM
Enochian Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Net Income | 189.18K | -7.25M | -44.21M | 39,684B | n/a | -39,684B | -4.33M | -4.46M | -7.7M | -90.24M | -6.2M | -6.58M | -10.41M | -17.36M | -4.03M | -2.93M | -2.4M |
Depreciation & Amortization | 31.98K | 32.11K | 32.38K | -113.5B | n/a | 113.5B | 28.24K | 28.84K | 28.4K | 28.33K | 31.72K | 31.8K | 31.73K | 299.37K | 30.82K | 30.76K | 30.46K |
Stock-Based Compensation | 1.5M | 558.63K | 357.65K | -3,535B | n/a | 3,535B | 1.08M | 819.96K | 1.03M | 141.66K | 577.68K | 2.04M | 2.73M | 259.82K | 499.43K | 359.39K | 326.16K |
Other Working Capital | -319.15K | -63.69K | n/a | 3,895B | n/a | -3,895B | -74.69K | 277K | 50.37K | 931.74K | 263.76K | -42.39K | -819.3K | 999.38K | -170.4K | 493.24K | -117.77K |
Other Non-Cash Items | -217.86K | 6.12M | n/a | -24,260.9B | n/a | 24,261B | 74.62K | 74.62K | 493.8K | 85.17M | 2.22M | 310.89K | 2.97M | 2.96M | 1.02M | -352.8K | -287.44K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -68.66K | 68.66K | -199.91K | 67.3K | 66.63K | 65.98K |
Change in Working Capital | -2.99M | -2.02M | n/a | 3.48M | n/a | -3.32M | -158.56K | 149.48K | 3.33M | 1.85M | 584.03K | -423.51K | -592K | 815.08K | 145.54K | 399.78K | -428.27K |
Operating Cash Flow | -1.49M | -2.56M | -2.02M | 11,774.5B | n/a | -11,774.5B | -3.31M | -3.38M | -2.82M | -3.05M | -2.78M | -4.62M | -5.28M | -13.03M | -2.33M | -2.5M | -2.76M |
Capital Expenditures | n/a | n/a | n/a | 29.77B | n/a | -29.77B | n/a | -23.63K | n/a | n/a | n/a | n/a | -5.16K | -38.17K | n/a | -10.72K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -1.46M | n/a | n/a | -1.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.46M | n/a | n/a | 29.77B | n/a | -29.77B | n/a | -23.63K | n/a | n/a | n/a | n/a | -5.16K | -38.17K | n/a | -10.72K | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 6.38M | 2.59M | 2.03M | -3,315B | n/a | 4,515.1B | 2.11M | -466.63K | 1.63M | 4,250.5B | 229.53K | 2.95M | n/a | 29.2M | 3.44M | -40.41K | n/a |
Financial Cash Flow | 3.58M | 2.59M | 2.03M | -4,515B | n/a | 4,515.1B | 2.11M | -466.63K | 1.63M | 1.07M | 229.53K | 2.95M | n/a | 29.2M | 3.44M | -40.41K | n/a |
Net Cash Flow | 611.24K | 91.19K | 104.00 | n/a | n/a | 1,874.5B | -1.17M | -3.85M | -1.2M | -1.98M | -2.56M | -1.67M | -5.29M | 16.14M | 1.1M | -2.54M | -2.73M |
Free Cash Flow | -1.49M | -2.56M | -2.02M | 11,804.3B | n/a | -11,804.3B | -3.31M | -3.41M | -2.82M | -3.05M | -2.78M | -4.62M | -5.28M | -13.07M | -2.33M | -2.51M | -2.76M |